Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Takuya Tsunoda0
Yusuke Nakamura0
Yoichi Furukawa0
Ryuji Ohsawa0
Sachiko Yoshimura0
Tomohisa Watanabe0
Date of Patent
May 22, 2018
0Patent Application Number
152287850
Date Filed
August 4, 2016
0Patent Primary Examiner
Patent abstract
The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 45, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include the above mentioned amino acid sequence with substitution deletion, or addition of one, two, or several amino acids sequences. The invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for diagnosing or treating cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.